Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: a state-of-the-heart review
journal contributionposted on 28.03.2022, 13:42 authored by Talal Almas, Sarah Rehman, Eyad Mansour, Tarek Khedro, Ali Alansari, Jahanzeb Malik, Norah Alshareef, Vikneswaran Raj NagarajanVikneswaran Raj Nagarajan, Abdulla Hussain Al-Awaid, Reema Alsufyani, Majid Alsufyani, Ali Rifai, Ahlam Alzahrani, Dhineswaran Raj Nagarajan, Tala Abdullatif, Varman Gunasaegaram, Enaam Alzadjali, Arthi Subramanian, Abida Rahman, Yasar Sattar, Jason Galo, Hafeez Ul Hassan Virk, M Chadi Alraies
The coronavirus disease 2019 (COVID-19) has overwhelming healthcare systems globally. To date, a myriad of therapeutic regimens has been employed in an attempt to curb the ramifications of a severe COVID-19 infection. Amidst the ongoing pandemic, the advent and efficacious uptake of COVID-19 vaccination has significantly reduced disease-related hospitalizations and mortality. Nevertheless, many side-effects are being reported after COVID-19 vaccinations and myocarditis is the most commonly reported sequelae post vaccination. Majority of these diseases are associated with COVID-19 mRNA vaccines. Various studies have established a temporal relationship between these complications, yet the causality and the underlying pathogenesis remain hypothetical. In this review, we aim to critically appraise the available literature regarding the cardiovascular side effects of the various mRNA vaccines and the associated pathophysiology.
CommentsThe original article is available at https://www.sciencedirect.com/
Published CitationAlmas T, et al. Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: a state-of-the-heart review. Biomed Pharmacother. 2022;149:112843.
Publication Date21 March 2022
- Undergraduate Research
- Published Version (Version of Record)